Integrating oxaliplatin with highly luminescent carbon dots: an unprecedented theranostic agent for personalized medicine.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24634004.
- Also identified by DOI 10.1002/adma.201306192.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A theranostic nanomedicine (CD-Oxa) is synthesized by means of the condensation reaction between the amino groups on the surface of fluorescent carbon dots (CDs) and the carboxyl group of the oxaliplatin derivative Oxa(IV)-COOH. CD-Oxa, which integrates the optical properties of CDs and the anticancer function of oxaliplatin, could be used for simultaneous drug delivery and fluorescent tracking.
Medical subject headings
- Antineoplastic Agents
- Carbon Compounds, Inorganic
- Fluorescence
- Organoplatinum Compounds
- Quantum Dots